Trial Outcomes & Findings for Low-level Laser Therapy in Patients With Chronic Fibromyalgia (NCT NCT02948634)
NCT ID: NCT02948634
Last Updated: 2020-03-03
Results Overview
Self-Report Questionnaire containing 21 questions, maximum/worse score=100; minimum/best score=0.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
28 participants
Primary outcome timeframe
baseline, 1 week, and 1 month after treatment
Results posted on
2020-03-03
Participant Flow
Participant milestones
| Measure |
Sham Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
|---|---|---|
|
Overall Study
STARTED
|
17
|
11
|
|
Overall Study
COMPLETED
|
7
|
9
|
|
Overall Study
NOT COMPLETED
|
10
|
2
|
Reasons for withdrawal
| Measure |
Sham Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
|---|---|---|
|
Overall Study
Lack of efficacy and study suspended
|
10
|
2
|
Baseline Characteristics
Low-level Laser Therapy in Patients With Chronic Fibromyalgia
Baseline characteristics by cohort
| Measure |
Sham Phoenix Laser Treatment
n=17 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
n=11 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
Total
n=28 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
53.0 years
STANDARD_DEVIATION 10.3 • n=99 Participants
|
53.0 years
STANDARD_DEVIATION 10.2 • n=107 Participants
|
53.0 years
STANDARD_DEVIATION 10.2 • n=206 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=99 Participants
|
11 Participants
n=107 Participants
|
28 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
% white
|
75 percent
n=99 Participants
|
75 percent
n=107 Participants
|
75 percent
n=206 Participants
|
|
Race/Ethnicity, Customized
% black
|
25 percent
n=99 Participants
|
25 percent
n=107 Participants
|
25 percent
n=206 Participants
|
|
Revised Symptom Impact Questionnaire
|
62.0 units on a scale
STANDARD_DEVIATION 7.6 • n=99 Participants
|
68.3 units on a scale
STANDARD_DEVIATION 14.8 • n=107 Participants
|
65.7 units on a scale
STANDARD_DEVIATION 12.5 • n=206 Participants
|
PRIMARY outcome
Timeframe: baseline, 1 week, and 1 month after treatmentSelf-Report Questionnaire containing 21 questions, maximum/worse score=100; minimum/best score=0.
Outcome measures
| Measure |
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
|---|---|---|
|
The Revised Symptom Impact Questionnaire
Baseline
|
62.0 score on a scale
Standard Deviation 7.6
|
68.3 score on a scale
Standard Deviation 14.8
|
|
The Revised Symptom Impact Questionnaire
1 week
|
47.1 score on a scale
Standard Deviation 21.8
|
50.5 score on a scale
Standard Deviation 22.5
|
|
The Revised Symptom Impact Questionnaire
1 month
|
45.8 score on a scale
Standard Deviation 22.5
|
50.2 score on a scale
Standard Deviation 25.3
|
SECONDARY outcome
Timeframe: baseline, 1 week, and 1 month after treatmentPain Domain: 2 Questions, 0 minimum/worse score, 100 maximum/best score
Outcome measures
| Measure |
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
|---|---|---|
|
RAND 36-Item Health Survey
Baseline
|
27.2 score on a scale
Standard Deviation 13.0
|
27.2 score on a scale
Standard Deviation 15.2
|
|
RAND 36-Item Health Survey
1 week
|
33.6 score on a scale
Standard Deviation 2.7
|
37.8 score on a scale
Standard Deviation 20.6
|
|
RAND 36-Item Health Survey
1 month
|
41.8 score on a scale
Standard Deviation 5.5
|
36.4 score on a scale
Standard Deviation 22.6
|
SECONDARY outcome
Timeframe: 1 week and 1 month after treatmentSelf report tool describing the degree of change since baseline. Minimum/worse value is -7. Maximum/best value is +7.
Outcome measures
| Measure |
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy.
Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
|
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes.
Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
|
|---|---|---|
|
Global Rating of Change Scale
1 week
|
0.4 score on a scale
Standard Deviation 3.3
|
2.8 score on a scale
Standard Deviation 2.0
|
|
Global Rating of Change Scale
1 month
|
0 score on a scale
Standard Deviation 3.1
|
1.3 score on a scale
Standard Deviation 3.9
|
Adverse Events
Sham Phoenix Laser Treatment
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Active Phoenix Laser Treatment
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place